Gender and Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation

Biol Blood Marrow Transplant. 2016 Jun;22(6):1145-1146. doi: 10.1016/j.bbmt.2016.03.020. Epub 2016 Mar 24.

Authors

Alois Gratwohl¹, Carmen Ruiz de Elvira², Michael Gratwohl³, Hildegard T Greinix⁴, Rafael Duarte⁵; Graft-versus-Host Disease Subcommittee of the Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation

Affiliations

¹ Department of Hematology, Medical Faculty, University of Basel, Basel, Switzerland. Electronic address: Alois.gratwohl@unibas.ch.
² European Society for Blood and Marrow Transplantation Data Office, London, United Kingdom.
³ University of St. Gallen and SCCER CREST, Switzerland.
⁴ Division of Hematology, Medical University of Graz, Graz, Austria.
⁵ Department of Hematology, University Hospital Puerta de Hierro Majadahonda, Madrid, Spain.

PMID: 27032302
DOI: 10.1016/j.bbmt.2016.03.020

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Gender Identity
Graft vs Host Disease / etiology*
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / methods
Humans
Male
Retrospective Studies
Transplantation Conditioning / adverse effects*
Transplantation Conditioning / methods